Composition
- Active ingredients
- RILZABRUTINIB 400MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA219685.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Wayrilz
- Active substance
- rilzabrutinib
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Genzyme Corp
- Status
- Prescription
- FDA approval
- 29 Aug 2025
- Application
- NDA219685-001